199 related articles for article (PubMed ID: 11073831)
1. Regulation of mRNA and protein levels of beta1 integrin variants in human prostate carcinoma.
Perlino E; Lovecchio M; Vacca RA; Fornaro M; Moro L; Ditonno P; Battaglia M; Selvaggi FP; Mastropasqua MG; Bufo P; Languino LR
Am J Pathol; 2000 Nov; 157(5):1727-34. PubMed ID: 11073831
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of the beta1C integrin splice variant in human prostate adenocarcinoma.
Moro L; Greco M; Ditonno P; Battaglia M; Marra E; Perlino E
Int J Oncol; 2003 Dec; 23(6):1601-6. PubMed ID: 14612932
[TBL] [Abstract][Full Text] [Related]
3. p27(kip1) acts as a downstream effector of and is coexpressed with the beta1C integrin in prostatic adenocarcinoma.
Fornaro M; Tallini G; Zheng DQ; Flanagan WM; Manzotti M; Languino LR
J Clin Invest; 1999 Feb; 103(3):321-9. PubMed ID: 9927492
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of beta1 integrin expression in the physio/pathological states of human endometrial tissues.
Moro L; Greco M; Maiorano E; Selvaggi L; Marra E; Perlino E
Int J Oncol; 2005 Feb; 26(2):457-65. PubMed ID: 15645131
[TBL] [Abstract][Full Text] [Related]
5. Androgen deprivation therapy regulation of beta1C integrin expression in prostate cancer.
Fuzio P; Lucarelli G; Perlino E; Battaglia M; Bettocchi C; Selvaggi FP; Ditonno P
Oncol Rep; 2009 Aug; 22(2):327-35. PubMed ID: 19578773
[TBL] [Abstract][Full Text] [Related]
6. Beta1C integrin in epithelial cells correlates with a nonproliferative phenotype: forced expression of beta1C inhibits prostate epithelial cell proliferation.
Fornaro M; Manzotti M; Tallini G; Slear AE; Bosari S; Ruoslahti E; Languino LR
Am J Pathol; 1998 Oct; 153(4):1079-87. PubMed ID: 9777939
[TBL] [Abstract][Full Text] [Related]
7. beta1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts.
Goel HL; Breen M; Zhang J; Das I; Aznavoorian-Cheshire S; Greenberg NM; Elgavish A; Languino LR
Cancer Res; 2005 Aug; 65(15):6692-700. PubMed ID: 16061650
[TBL] [Abstract][Full Text] [Related]
8. Regulation of beta1C and beta1A integrin expression in prostate carcinoma cells.
Moro L; Perlino E; Marra E; Languino LR; Greco M
J Biol Chem; 2004 Jan; 279(3):1692-702. PubMed ID: 14585844
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of protein and mRNA expression for transforming growth factor-beta (TGF-beta1) type I and type II receptors in human prostate cancer.
Guo Y; Jacobs SC; Kyprianou N
Int J Cancer; 1997 May; 71(4):573-9. PubMed ID: 9178810
[TBL] [Abstract][Full Text] [Related]
10. Beta1 integrins modulate cell adhesion by regulating insulin-like growth factor-II levels in the microenvironment.
Goel HL; Moro L; King M; Teider N; Centrella M; McCarthy TL; Holgado-Madruga M; Wong AJ; Marra E; Languino LR
Cancer Res; 2006 Jan; 66(1):331-42. PubMed ID: 16397247
[TBL] [Abstract][Full Text] [Related]
11. Identification of beta1C-2, a novel variant of the integrin beta1 subunit generated by utilization of an alternative splice acceptor site in exon C.
Svineng G; Fässler R; Johansson S
Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1255-63. PubMed ID: 9494094
[TBL] [Abstract][Full Text] [Related]
12. Microautoradiographic quantitation of vascular endothelial growth factor mRNA levels in human prostate specimens containing normal and neoplastic epithelium.
Woessner RD; Wright PS; Loudy DE; Wallace CD; Montgomery LR; Nestok BR
Exp Mol Pathol; 1998; 65(1):37-52. PubMed ID: 9613925
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of drs mRNA in human prostate carcinomas.
Kim CJ; Shimakage M; Kushima R; Mukaisho K; Shinka T; Okada Y; Inoue H
Hum Pathol; 2003 Jul; 34(7):654-7. PubMed ID: 12874760
[TBL] [Abstract][Full Text] [Related]
14. β1 integrin deletion enhances progression of prostate cancer in the TRAMP mouse model.
Moran-Jones K; Ledger A; Naylor MJ
Sci Rep; 2012; 2():526. PubMed ID: 22829980
[TBL] [Abstract][Full Text] [Related]
15. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of beta 1C integrin, an inhibitor of cell proliferation, in prostate carcinoma.
Fornaro M; Tallini G; Bofetiado CJ; Bosari S; Languino LR
Am J Pathol; 1996 Sep; 149(3):765-73. PubMed ID: 8780381
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of cell cycle inhibition by integrin beta1C.
Meredith JE; Kiosses WB; Takada Y; Schwartz MA
J Biol Chem; 1999 Mar; 274(12):8111-6. PubMed ID: 10075712
[TBL] [Abstract][Full Text] [Related]
18. beta 1C Integrin expression in human endometrial proliferative diseases.
Lovecchio M; Maiorano E; Vacca RA; Loverro G; Fanelli M; Resta L; Stefanelli S; Selvaggi L; Marra E; Perlino E
Am J Pathol; 2003 Dec; 163(6):2543-53. PubMed ID: 14633626
[TBL] [Abstract][Full Text] [Related]
19. Expression of putative stem cell genes Musashi-1 and beta1-integrin in human colorectal adenomas and adenocarcinomas.
Fan LF; Dong WG; Jiang CQ; Xia D; Liao F; Yu QF
Int J Colorectal Dis; 2010 Jan; 25(1):17-23. PubMed ID: 19714342
[TBL] [Abstract][Full Text] [Related]
20. β1 integrin- and JNK-dependent tumor growth upon hypofractionated radiation.
Sayeed A; Lu H; Liu Q; Deming D; Duffy A; McCue P; Dicker AP; Davis RJ; Gabrilovich D; Rodeck U; Altieri DC; Languino LR
Oncotarget; 2016 Aug; 7(33):52618-52630. PubMed ID: 27438371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
